Specialized in liquid pharmaceuticals: Blow-Fill-Seal (BFS) technology and Nasal Spray.

Read More


Your partner in bringing medical innovation to the market.

Read More

About Curida

Highly skilled Development and Manufacturing Organization with ambitions.

Read More

Contact Curida

Pharmaceutical Development or Manufacturing needs?

Contact Us

Operational Excellence in Pharmaceuticals since 1974

Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical industry, based in Norway.

Curida has core competency in state-of-the-art manufacturing of Liquid Pharmaceuticals based on sterile unit-dose Blow-Fill-Seal (BFS) technology and Nasal Spray. The development expertise covers the full service for the development of nasal drug products, and experience on operational excellence is spanning more than 40 years. Curida has produced BFS products since 1989 and offers over three decades of know-how in this technology. Customers range from small start-ups and early stage Biotech companies to Big Pharma.

Curida is a part of an exciting and growing life science sector in Norway, and our vision is to be the National Centre for Industrialization of Medical Innovation. Curida is an active partner and member of Oslo Cancer Cluster.

Latest News

Curida CEO to present at the Annual Conference of the Confederation of Norwegian Enterprise (NHO)

Published: 04 Jan 2017

Leif Rune Skymoen, CEO of Curida, will speak at the Annual Conference of the Confederation of Norwegian Enterprise (NHO) in Oslo Spektrum on January 5th. The audience will include The Royal Highnesses Crown Prince Haakon Magnus and Crown Princess Mette-Marit […]

Read More

Group led by Curida to take over manufacturing equipment from Norwegian Institute for Public Health

Published: 28 Nov 2016

A network of pharmaceutical companies, led by the Norwegian Contract Development and Manufacturing Organisation Curida, will acquire essential equipment for manufacturing of vaccines, when the production facilities at the Norwegian Institute for Public Health (NIPH) close down in July 2017. […]

Read More